Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

United States — Food and Drug Administration & Kyle Diamantas

10 shared events · Importance 3 · Last updated Sep 07, 2026

Importance
3
Shared Events
10
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
77
Regulatory
United States — Food and Drug Administration: The FDA is the central regulator proposing the new notification requirement and completing the ultraprocessed food definition, enhancing its oversight role.
Kyle Diamantas: As acting FDA Commissioner, Diamantas is the public face of the proposal, articulating its benefits for postmarket safety.
Aug 10, 2026 · 12 articles
77
Regulatory
United States — Food and Drug Administration: The FDA formalizes cooperation with the SEC, enhancing its role in referring potential securities violations and supporting market integrity, while maintaining confidentiality controls.
Kyle Diamantas: As Acting FDA Commissioner, Diamantas signed the MOU, supporting transparency and cooperation with the SEC.
Aug 31, 2026 · 6 articles
71
Domestic
United States — Food and Drug Administration: The FDA is the agency being led. It faces staff losses, morale issues, and policy controversies; Overton's nomination could exacerbate these challenges.
Kyle Diamantas: Diamantas has been acting FDA chief since May, providing some stability. His future role is uncertain under a new commissioner.
Aug 19, 2026 · 101 articles
71
Regulatory
United States — Food and Drug Administration: The FDA is the subject of the restructuring, which could reshape its leadership and regulatory approach, affecting drug approvals and AI oversight.
Kyle Diamantas: Diamantas, acting FDA commissioner, may return to his previous deputy role; his tenure saw reversals on some drug approvals.
Aug 25, 2026 · 6 articles
55
Accidents
United States — Food and Drug Administration: The FDA led the investigation, linking the outbreak to Taylor Farms lettuce. It faced criticism for a false-positive test result and for potential influence by the United States — White House, but it continues to work on the investigation.
Kyle Diamantas: Acting FDA Commissioner Kyle Diamantas announced the false-positive test result, which complicated the investigation.
Jul 08, 2026 · 358 articles
55
Regulatory
United States — Food and Drug Administration: The FDA granted approval for mFLUSIVA, marking a regulatory milestone and demonstrating its role in vaccine oversight despite internal controversies.
Kyle Diamantas: As acting FDA Commissioner, Diamantas sought to rebuild industry confidence after the controversies.
Aug 05, 2026 · 105 articles
55
Regulatory
United States — Food and Drug Administration: The FDA granted expedited approval to daraxonrasib, marking a regulatory milestone and demonstrating its commitment to accelerating cancer treatments. The approval was issued 6.5 months ahead of schedule, reflecting the agency's priority review process.
Kyle Diamantas: As acting FDA Commissioner, Kyle Diamantas announced the approval, emphasizing the agency's duty to deliver treatments quickly, and oversaw the expedited review process.
Aug 26, 2026 · 92 articles
0
International
Kyle Diamantas: Kyle Diamantas is expected to take over as acting commissioner of the United States — Food and Drug Administration.
Apr 16, 2026 · 760 articles
0
Domestic
Kyle Diamantas: Kyle Diamantas, the United States — Food and Drug Administration's deputy commissioner for foods, is tasked with developing a definition for 'ultra-processed foods' and is the first non-scientist to head the United States — Food and Drug Administration in over half a century, raising concerns among critics.
May 13, 2026 · 6 articles
0
Domestic
Kyle Diamantas: Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
May 08, 2026 · 114 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Kyle Diamantas interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.